PETER DEVUYST: Open Payments
NPI 1457369647 · FORT WALTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,990 in 128 payments from 23 companies in 2025. Trend: 2023 $2,178 · 2024 $2,189 · 2025 $2,990
Food & beverage: $2,803Education: $163Consulting: $24
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 20 | $621 |
| AstraZeneca Pharmaceuticals LP | 19 | $463 |
| Insmed, Inc. | 14 | $370 |
| GENZYME CORPORATION | 10 | $265 |
| GlaxoSmithKline, LLC. | 18 | $214 |
| Amgen Inc. | 9 | $180 |
| CSL Behring | 7 | $168 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Grifols USA, LLC | 3 | $87 |
| Pharming Healthcare, Inc. | 4 | $71 |
Products named: DUPIXENT, Arikayce, TEZSPIRE, AIRSUPRA, TRELEGY ELLIPTA, FASENRA, Prolastin-C Liquid, AYVAKIT.
Industry payments across FL — which companies pay providers there.
